PERRIGO FIRST-QUARTER SALES INCREASE 6% TO $182.7 MIL.
This article was originally published in The Tan Sheet
Executive Summary
PERRIGO FIRST-QUARTER SALES INCREASE 6% TO $182.7 MIL. led by gains in analgesics, vitamins, cough and cold remedies and antacids, the company said in an Oct. 28 release. The company said it achieved "moderate" sales growth for the three-month period ended Sept. 30 despite a "later start to the cough and cold season this year and a soft market in analgesics."